|
Active substance |
iNOmax |
|
Holder |
Fluidda nv |
|
Status |
closed |
|
Indication |
patients who suffer from pulmonary hypertension associated with COPD and who participated in the PULSE-COPD-007 study |
|
Public documents |
|
|
Last update |
28/08/2023 |
iNOmax®
Last updated on 10/09/2024